封面
市場調查報告書
商品編碼
2076153

抗過敏治療藥物市場:按藥物類型、應用、分銷管道和地區分類

Allergy Treatment Drugs Market, By Drug Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,過敏治療市場規模將達350億美元,到2033年將達到588.3億美元。預計從2026年到2033年,該市場將以7.7%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 350億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.70% 2033年市場規模預測: 588.3億美元

全球過敏治療市場涵蓋多種藥物類別,包括生物製藥、免疫療法和抗組織胺藥,用於治療呼吸道過敏、皮膚過敏和食物過敏等疾病。醫院和零售藥局的廣泛應用以及對更有效率、更可靠解決方案的需求是推動市場成長的主要因素。持續的技術進步和不斷成長的終端用戶需求正在推動該市場的發展。

市場動態:

呼吸道和皮膚過敏領域應用範圍的擴大、終端用戶需求的成長以及對提高效率和性能的持續關注,預計將成為全球過敏治療市場成長的主要驅動力。更廣泛的選擇也使得這些解決方案能夠惠及更多用戶。

例如,各公司正在拓展產品系列,以滿足醫院藥局和零售藥局不斷變化的需求。此外,預計在預測期內,加大對創新和新技術整合的投資將為市場參與者創造新的成長機會。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球過敏治療市場主要參與者的概況。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球過敏治療市場》報告的目標受群眾外包括業界的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球過敏治療市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • 主要進展
  • PEST分析
  • 夥伴關係方案
  • 品牌和定價分析
  • 銷售代理情況
  • 波特的分析
  • 技術進步
  • 主要進展
  • 市場趨勢
  • 前景
  • 按銷售收入排名的主要公司

第4章 抗過敏治療藥物市場:依藥物類型分類,2026-2033年

  • 生物製劑
  • 免疫療法
  • 抗組織胺藥
  • 皮質類固醇
  • 其他

第5章 抗過敏治療藥物市場:依通路分類,2026-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 其他

第6章 過敏治療市場:依應用領域分類,2026-2033年

  • 呼吸道過敏
  • 皮膚過敏
  • 食物過敏
  • 其他

第7章 過敏治療市場:依地區分類,2026-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 比荷盧經濟聯盟
    • 丹麥
    • 挪威
    • 瑞典
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 台灣
    • 印度
    • 日本
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 新加坡
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東和非洲
    • 巴林
    • 科威特
    • 阿曼
    • 卡達
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 北非
    • 中非
    • 其他中東國家

第1章 競爭情勢

  • Pfizer Inc.
  • GlaxoSmithKline plc,
  • Sanofi SA
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca plc
  • Merck & Co.
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • CSL Limited
  • Viatris Inc.

第2章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI3499

Allergy Treatment Drugs Market is estimated to be valued at USD 35.00 billion in 2026 and is expected to reach USD 58.83 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 35.00 billion
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 58.83 billion

The global allergy treatment drugs market covers a broad set of drug type categories, including Biologics, Immunotherapy, and Antihistamines, used across applications such as Respiratory Allergies, Dermatological Allergies, and Food Allergies. Demand is supported by adoption among Hospital Pharmacies, and Retail Pharmacies and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Respiratory Allergies, and Dermatological Allergies, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global allergy treatment drugs market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Hospital Pharmacies, and Retail Pharmacies. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global allergy treatment drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Johnson & Johnson, AstraZeneca plc, Merck & Co., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., CSL Limited, and Viatris Inc, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global allergy treatment drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment drugs market.

Detailed Segmentation:

  • Global Allergy Treatment Drugs Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
  • Biologics
  • Immunotherapy
  • Antihistamines
  • Corticosteroids
  • Others
  • Global Allergy Treatment Drugs Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Respiratory Allergies
  • Dermatological Allergies
  • Food Allergies
  • Others
  • Global Allergy Treatment Drugs Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Pfizer Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca plc
  • Merck & Co.
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • CSL Limited
  • Viatris Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • tAssumptions
  • Abbreviations

2. Market Preview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Partnership Scenario
  • Brand and Pricing Analysis
  • Distributors Landscape
  • Porters Analysis
  • Technological Advancements
  • Key Developments
  • Market Trend
  • Future Prospective
  • Top Market Players by Revenue

4. Allergy Treatment Drugs Market By Drug Type, 2026-2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Antihistamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Allergy Treatment Drugs Market By Distribution Channel, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Allergy Treatment Drugs Market By Application, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Respiratory Allergies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Dermatological Allergies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Food Allergies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Allergy Treatment Drugs Market By Region, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, en2026-2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Benelux
      • Denmark
      • Norway
      • Sweden
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • China
      • Taiwan
      • India
      • Japan
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  • Bahrain
  • Kuwait
  • Oman
  • Qatar
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of the Middle East

1. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline plc,
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Regeneron Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CSL Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Viatris Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

2. Section

  • Research Methodology
  • About Us